The inhibition of miR-17-5p and/or miR-106-5p leads to the restoration of TRIM8-mediated TP53 tumor suppressor activity and inhibits N-MYC-dependent cell proliferation through miR-34a upregulation [65];. Here, TRIM8 is linked to neoplasm.